These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35348331)

  • 1. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors.
    Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H
    ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
    Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
    Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy.
    Shan L; Fan W; Wang W; Tang W; Yang Z; Wang Z; Liu Y; Shen Z; Dai Y; Cheng S; Jacobson O; Zhai K; Hu J; Ma Y; Kiesewetter DO; Gao G; Chen X
    ACS Nano; 2019 Aug; 13(8):8903-8916. PubMed ID: 31374171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression.
    Hang L; Zhang T; Wen H; Li M; Liang L; Tang X; Zhou C; Tian J; Ma X; Jiang G
    Theranostics; 2021; 11(20):10001-10011. PubMed ID: 34815800
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
    Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
    ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-accelerating H
    Tang Y; Ji Y; Yi C; Cheng D; Wang B; Fu Y; Xu Y; Qian X; Choonara YE; Pillay V; Zhu W; Liu Y; Nie Z
    Theranostics; 2020; 10(19):8691-8704. PubMed ID: 32754272
    [No Abstract]   [Full Text] [Related]  

  • 7. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
    Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a sequential release nanomaterial for co-delivery of hypoxia-induced tirapazamine and HIF-1α siRNA in cancer therapy.
    Zhang X; Bai Z; Cui Z; Liang W; Shi M; Liu Z; Li K; Wang J; Jiao T; Li J
    Colloids Surf B Biointerfaces; 2025 Jan; 245():114260. PubMed ID: 39305549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Janus Gold Triangle-Mesoporous Silica Nanoplatforms for Hypoxia-Activated Radio-Chemo-Photothermal Therapy of Liver Cancer.
    Wang Z; Chang ZM; Shao D; Zhang F; Chen F; Li L; Ge MF; Hu R; Zheng X; Wang Y; Dong WF
    ACS Appl Mater Interfaces; 2019 Sep; 11(38):34755-34765. PubMed ID: 31474108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
    Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
    Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H
    Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
    J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodrug and Glucose Oxidase Coloaded Photodynamic Hydrogels for Combinational Therapy of Melanoma.
    Zhou J; Liu C; Wang Y; Ding M; Yu N; Liu D; Zhang Q; Li J
    ACS Biomater Sci Eng; 2022 Nov; 8(11):4886-4895. PubMed ID: 36278808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
    Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
    Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
    Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-infrared photoactivatable three-in-one nanoagents to aggravate hypoxia and enable amplified photo-chemotherapy.
    Yu N; Zhou J; Xu H; Wang F; Wang X; Tang L; Li J; Wang X; Lu X
    Biomater Adv; 2024 Oct; 163():213962. PubMed ID: 39032435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH/GSH dual-responsive supramolecular nanomedicine for hypoxia-activated combination therapy.
    Du C; Wang C; Jiang SH; Zheng X; Li Z; Yao Y; Ding Y; Chen T; Yi H
    Biomater Sci; 2023 Aug; 11(16):5674-5679. PubMed ID: 37439102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Starvation Induced Spatiotemporal Control over Chemotherapy for Synergistic Therapy.
    Zhang MK; Li CX; Wang SB; Liu T; Song XL; Yang XQ; Feng J; Zhang XZ
    Small; 2018 Dec; 14(50):e1803602. PubMed ID: 30370690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
    Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
    J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioresponsive diselenide-functionalized hydrogel with cascade catalytic activities for enhanced local starvation- and hypoxia-activated melanoma therapy.
    Ding X; Zang M; Zhang Y; Chen Y; Du J; Yan A; Gu J; Li Y; Wei S; Xu J; Sun H; Liu J; Yu S
    Acta Biomater; 2023 Sep; 167():182-194. PubMed ID: 37339693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.